A simple blood test could detect Alzheimer’s disease with 100% accuracy, according to research from Resonant, a Utah biotech ...
Investing in most current Alzheimer's drug companies is not recommended because they are not likely to modify the disease.
BLUFFTON, S.C. (WCSC) - One of the first Alzheimer’s patients in the Lowcountry to take part in Leqembi infusion treatments ...
CHICAGO, Nov 20 (Reuters) - Breakthrough Alzheimer’s treatments that remove toxic proteins from the brain have revived interest in vaccines to treat the memory-robbing disease, potentially ...
Citation: New Alzheimer's drug shines light on need for assessments to head off 'a tsunami of cognitive afflictions' (2023, November 20) retrieved 3 December 2023 from https://medicalxpress.com ...
Anavex's Alzheimer's drug Blarcamesine demonstrates strong statistical significance in improving cognition among dementia patients as measured by one co-primary endpoint and one secondary endpoint.
Nov. 30, 2023 — Researchers are collaborating on a novel approach to use neuroimaging and network modeling tools -- previously developed to analyze brains of patients in the clinic -- to ...
Move over, Ozempic — there’s a new drug in town. Eli Lilly’s Zepbound, with the active ingredient tirzepatide, has been approved by the Food and Drug Administration for use by obese or ...
As the sun sets, problems arise - especially for those affected by Alzheimer's disease. This is largely because a change in schedule can cause confusion. It's what the term 'sundowning' means.
In a detailed study, Diet's Role in Modifying Risk of Alzheimer's Disease: History and Present Understanding published in the Journal of Alzheimer's Disease, we can finally see which diets are helpful ...
CHICAGO, Nov 20 (Reuters) - Breakthrough Alzheimer’s treatments that remove toxic proteins from the brain have revived interest in vaccines to treat the memory-robbing disease, potentially ...
